Replies to post #114687 on Biotech Values

[10nisman]

An analyst at Monness, Crespi, Hardt downgraded shares of Momenta Pharmaceuticals from Buy to Neutral in an intraday note today. The stock dipped in mid-day trading as the downgrade began hitting wires, however shares seem to be bouncing.

Anyone have the report that they could post? TIA.

10nis